Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis

PURPOSE: To understand the functional and preclinical efficacy of targeting urokinase plasminogen activator receptor (u-PAR) in ovarian cancer. EXPERIMENTAL DESIGN: Expression of u-PAR was studied in 162 epithelial ovarian cancers, including 77 pairs of corresponding primary and metastatic tumors. T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kenny, Hilary A., Leonhardt, Payton, Ladanyi, Andras, Yamada, S. Diane, Montag, Anthony, Im, Hae Kyung, Jagadeeswaran, Sujatha, Shaw, David E., Mazar, Andrew P., Lengyel, Ernst
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3073583/
https://ncbi.nlm.nih.gov/pubmed/21149615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-2258
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars